Prevention of malaria in travellers from the United Kingdom.
D000328:Adult; D000962:Antimalarials / Q000009:adverse effects / Q000627:therapeutic use; D003906:Developing Countries; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008288:Malaria / Q000517:prevention & control*; D008297:Male; D015767:Mefloquine / Q000009:adverse effects / Q000627:therapeutic use*; D011739:Pyrimethamine / Q000009:adverse effects / Q000627:therapeutic use; D011803:Quinine / Q000009:adverse effects / Q000627:therapeutic use; D013413:Sulfadoxine / Q000009:adverse effects / Q000627:therapeutic use; D014195:Travel; D006113:United Kingdom
D000962:Antimalarials; D004338:Drug Combinations; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D011803:Quinine; D015767:Mefloquine; D011739:Pyrimethamine